Oregon Health & Science University has been facing a series of mounting challenges in recent months, including its proposed merger with Legacy Health, which is being reviewed by the Oregon Health Authority. If approved, OHSU would control five of the six hospitals in Multnomah County, according to a report issued by OHA last November. 

OHSU has also had to contend with the departure of prominent executives such as the interim head of its health unit last month, and Dr. Brian Druker, a world renowned cancer researcher, who resigned in December as CEO of the Knight Cancer Institute. Among the reasons Druker shared with OPB for his decision included low staff morale, a lack of trust in OHSU’s leaders and the organization’s cost-cutting measures, such as its decision to lay off more than 500 employees. 

Leading OHSU during this turbulent time is Steve Stadum. The board of directors appointed him as interim president in November, marking his return to the organization which he first worked at more than 25 years ago. Stadum joins us to share his vision for OHSU and how he aims to navigate its internal and external challenges, including threats to federally funded research from the new Trump administration.